Professor David Attwell, Jodrell Professor of Physiology at UCL, and the study's co-lead, added: "With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of 'no-reflow' in heart attack patients, offering a potentially life-saving solution." Dr
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Murphy CC, Correa AM, Ajani JA, Komaki RU, Welsh JW, Swisher SG , Hofstetter WL
It is a small-molecule aminoketone metabolized primarily by CYP2B6 to its active metabolite hydroxybupropion [4]
Mech Dev 122(2):223230 Sasai N, Toriyama M, Kondo T (2019) Hedgehog signal and genetic disorders